ONWARD MEDICAL BV EO -12 Total Liabilities
ONWARD MEDICAL BV EO -12 total liabilities. Based on the latest financial reports, ONWARD MEDICAL BV EO -12 (63E) has total liabilities worth €29.24 Million EUR (≈ $34.18 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ONWARD MEDICAL BV EO -12 liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of ONWARD MEDICAL BV EO -12 (2021–2025)
Total liabilities of ONWARD MEDICAL BV EO -12 from 2021 to 2025. This chart illustrates how ONWARD MEDICAL BV EO -12's total liabilities have evolved over time, based on quarterly financial data.
ONWARD MEDICAL BV EO -12 Competitors by Total Liabilities
The table below lists competitors of ONWARD MEDICAL BV EO -12 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bergbahnen Engelberg Truebsee Titlis Bet AG
SW:TIBN
|
Switzerland | CHF120.20 Million |
|
Nam Viet Corp
VN:ANV
|
Vietnam | ₫2.30 Trillion |
|
Humm Group Ltd
AU:HUM
|
Australia | AU$4.54 Billion |
|
UNISEM Co. Ltd
KQ:036200
|
Korea | ₩42.73 Billion |
|
Sionna Therapeutics, Inc. Common Stock
NASDAQ:SION
|
USA | $19.12 Million |
|
Jai Corp Limited
NSE:JAICORPLTD
|
India | Rs-15.10 Billion |
|
Radcom Ltd
NASDAQ:RDCM
|
USA | $29.13 Million |
|
Omiris AG
F:HBD1
|
Germany | €1.83 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down ONWARD MEDICAL BV EO -12's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 63E asset base.
Liquidity & Leverage Metrics
ONWARD MEDICAL BV EO -12 Total Liabilities Ratios Explained
ONWARD MEDICAL BV EO -12 total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.67 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.53 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ONWARD MEDICAL BV EO -12's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ONWARD MEDICAL BV EO -12 (2021–2025)
The table below shows the annual total liabilities of ONWARD MEDICAL BV EO -12 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €29.24 Million ≈ $34.18 Million |
+4.11% |
| 2024-12-31 | €28.08 Million ≈ $32.83 Million |
+9.28% |
| 2023-12-31 | €25.70 Million ≈ $30.04 Million |
+7.24% |
| 2022-12-31 | €23.96 Million ≈ $28.01 Million |
+8.36% |
| 2021-12-31 | €22.11 Million ≈ $25.85 Million |
-- |
About ONWARD MEDICAL BV EO -12
Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company engages in developing ARCEX, a technology to enhance hand strength and sensation for individuals with SCI; ARCIM, a spinal cord stimulation system designed to address blood pressure instability and other symptoms in people wit… Read more